ELN gonna take off when it comes off that halt ))))) MS drug Tysabri should return, U.S. panel says
March 08, 2006 11:01:01 (ET)
GAITHERSBURG, Md., March 8 (Reuters) - Biogen Idec ((BIIB.O)) and Elan Corp.'s (ELN,Trade) ((ELN.I)) Tysabri multiple sclerosis drug should return to the U.S. market, an advisory panel recommended on Wednesday.
Tysabri sales were suspended in February 2005 after three patients developed a serious brain and spinal cord infection. Two of them died.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.